What is NDC 70954-976?

70954-976 is the product NDC for Sacubitril and Valsartan, Sacubitril 49 mg/1; Valsartan 51 mg/1 tablet, film coated, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sacubitril and Valsartan?

86 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sacubitril and Valsartan NDC 70954-976

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-976Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0976Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70954-976-20	70954097620	60 TABLET, FILM COATED in 1 BOTTLE (70954-976-20)Marketed from Jul 24, 2025
70954-976-30	70954097630	180 TABLET, FILM COATED in 1 BOTTLE (70954-976-30)Marketed from Jul 24, 2025
70954-976-50	70954097650	1000 TABLET, FILM COATED in 1 BOTTLE (70954-976-50)Marketed from May 27, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sacubitril and Valsartan
Generic name (nonproprietary): sacubitril and valsartan
Active ingredients: Sacubitril — 49 mg/1Valsartan — 51 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.NDC labeler code 70954
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213676
Marketing start: Jul 24, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Neprilysin Inhibitors (Mechanism)
Identifiers: Product ID 70954-976_fb8d85f8-7a85-422b-82f0-2a4f5d296b07SPL ID fb8d85f8-7a85-422b-82f0-2a4f5d296b07SPL set ID a1fa7066-8ab4-47e3-a701-6c5170700d11RxCUI 1656340, 1656349, 1656354UNII 17ERJ0MKGI, 80M03YXJ7IUPC 0370954977506, 0370954976202, 0370954977308, 0370954977209, 0370954975205, 0370954975304, 0370954975502, 0370954976509, 0370954976301
Pharmacologic class: Angiotensin 2 Receptor Blocker; Neprilysin Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954097620 followed by a unit qualifier and the quantity

Package 70954-0976-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Sacubitril and valsartan tablets are a combination of sacubitril, a neprilisin inhibitor, and valsartan, an angiotensin II receptor blocker, and is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal. (1.1) for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. Sacubitril and valsartan tablets reduce NT-proBNP and are expected to improve cardiovascular outcomes. (1.2) 1.1 Adult Heart Failure Sacubitril and valsart…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70954-976

What is NDC 70954-976?: 70954-976 is the product NDC for Sacubitril and Valsartan, Sacubitril 49 mg/1; Valsartan 51 mg/1 tablet, film coated, listed with the FDA by ANI Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sacubitril and Valsartan.
What is the active ingredient?: Sacubitril, Valsartan.
Who is the labeler?: ANI Pharmaceuticals, Inc., NDC labeler code 70954. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sacubitril and Valsartan?: 86 other product NDCs are listed under this name. See all Sacubitril and Valsartan NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sacubitril and Valsartan NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-085	60290-0085-0160290-0085-0260290-0085-03
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-086	60290-0086-0160290-0086-0260290-0086-03
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	Umedica Laboratories USA Inc.	60290-087	60290-0087-0160290-0087-0260290-0087-03
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-882	72603-0882-0172603-0882-02
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-880	72603-0880-0172603-0880-02
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-881	72603-0881-0172603-0881-02
sacubitril and valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-936	51407-0936-10
sacubitril and valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-935	51407-0935-10
sacubitril and valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-937	51407-0937-10
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-966	60687-0966-57

All 87 Sacubitril and Valsartan NDCs

Other NDCs under ANDA 213676

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213676
Product	Strength	Form · route	Labeler	Product NDC
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	ANI Pharmaceuticals, Inc.	70954-975
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	ANI Pharmaceuticals, Inc.	70954-977
Sacubitril and Valsartan	Sacubitril 97 mg/1; Valsartan 103 mg/1	Tablet, Film coatedOral	Laurus Labs Limited	42385-932
Sacubitril and Valsartan	Sacubitril 24 mg/1; Valsartan 26 mg/1	Tablet, Film coatedOral	Laurus Labs Limited	42385-930
Sacubitril and Valsartan	Sacubitril 49 mg/1; Valsartan 51 mg/1	Tablet, Film coatedOral	Laurus Labs Limited	42385-931